Euro Biogenetics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Ebitda
- Net Worth -181.69%
- Total Assets %
About Euro Biogenetics
Euro Biogenetics Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2011 and has a history of 13 years and four months. Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bikash Jaiswal and Vivek Jaiswal serve as directors at the Company.
Company Details
- Location
Howrah, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909WB2011PTC167761
- Company No.
167761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Euro Biogenetics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bikash Jaiswal  | Director | 19-Sep-2011 | Current |
| Vivek Jaiswal | Director | 02-Aug-2019 | Current |
Financial Performance of Euro Biogenetics.
Euro Biogenetics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 181.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Euro Biogenetics?
In 2020, Euro Biogenetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
De Euro Projects Private LimitedBikash Jaiswal is a mutual person
- Kamalpushp Developers Private Limited
Bikash Jaiswal is a mutual person
- De Eusi Motors Private Limited
Bikash Jaiswal is a mutual person
- De Euro Healthcare Private Limited
Bikash Jaiswal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Euro Biogenetics?
Unlock and access historical data on people associated with Euro Biogenetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euro Biogenetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euro Biogenetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
